ARALEZ PHARMACEUTICALS INC. Proceeds from Convertible Debt
ARALEZ PHARMACEUTICALS INC. reported Proceeds from Convertible Debt of $275.00 million for the 12-month period ending 2016-12-31, per its 10-K filed 2018-03-14.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromConvertibleDebt · last filed 2018-03-14
- ARALEZ PHARMACEUTICALS INC. proceeds from convertible debt for the quarter ending 2016-12-31 was $200.00M.
- ARALEZ PHARMACEUTICALS INC. proceeds from convertible debt for the quarter ending 2016-09-30 was $0.00.
- ARALEZ PHARMACEUTICALS INC. proceeds from convertible debt for the quarter ending 2016-06-30 was $0.00.
- ARALEZ PHARMACEUTICALS INC. proceeds from convertible debt for the quarter ending 2016-03-31 was $75.00M.
- ARALEZ PHARMACEUTICALS INC. proceeds from convertible debt for fiscal 2016 was $275.00M.
| Period end | Proceeds from Convertible Debt | Proceeds from Convertible Debt 3 month | Proceeds from Convertible Debt 6 month | Proceeds from Convertible Debt 9 month | Proceeds from Convertible Debt 12 month |
|---|---|---|---|---|---|
| 2016-12-31 | $200.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | $200.00M derived: sum of 2 quarters · filed 2018-03-14 | $200.00M derived: sum of 3 quarters · filed 2018-03-14 | $275.00M 10-K · filed 2018-03-14 | |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $0.00 derived: sum of 2 quarters · filed 2017-11-09 | $75.00M 10-Q · filed 2017-11-09 | ||
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $75.00M 10-Q · filed 2017-08-09 | |||
| 2016-03-31 | $75.00M 10-Q · filed 2017-05-09 | ||||
| 2016-02-05 | $75.00M 10-Q · filed 2016-05-10 |